KAT8 regulatory NSL complex subunit 1
Dernière mise à jour 18 Aug 2020
Respecte les directives éditoriales
- TéléchargerTélécharger
- Partager
- Language
- Discussion
- Ask Patient
- Version audio
- Ajouter aux sources préférées sur Google
La KANSL1 gene provides instructions for making a member (subunit) of a group of interacting proteins called the KAT8 regulatory NSL complex. This complex is categorized as a histone acetyltransferase (HAT) complex. It helps regulate gene activity (expression) by modifying chromatin, the complex of DNA and protein that packages DNA into chromosomes.
Sélections vidéo pour GènesBibliothèque vidéo
Normal function
La KANSL1 gene provides instructions for making a member (subunit) of a group of interacting proteins called the KAT8 regulatory NSL complex. This complex is categorized as a histone acetyltransferase (HAT) complex. It helps regulate gene activity (expression) by modifying chromatin, the complex of DNA and protein that packages DNA into chromosomes.
The protein produced from the KANSL1 gene is found in most organs and tissues of the body before birth and throughout life. By its involvement in controlling the activity of other genes, this protein plays an important role in the development and function of many parts of the body.
Conditions referring to this gene or chromosome
Other names
CENP-36
centromere protein 36
DKFZP727C091
hMSL1v1
KANL1_HUMAN
KDVS
KIAA1267
male-specific lethal 1 homolog
MLL1/MLL complex subunit KANSL1
MSL1 homolog 1
MSL1v1
non-specific lethal 1 homolog
NSL complex protein NSL1
NSL1
Related patient information and medicines

Patient information leaflet
Erreur médicale
La plupart personnes receive good care de healthcare professionals. There is a separate Médiateur du Service de Santé for England, Scotland, Wales and Northern Ireland. Governing bodies pour health professionals Healthcare professionals sont regulated by governing bodies, which have the power to prevent them from practising if they are unfit to do so. (In.

Patient information leaflet
Puis-je prendre de la Tétracycline et du Calcium ensemble ?
This is because the calcium binds to the medicine in your stomach, preventing... Why this happens This is a pharmacokinetic interaction involving absorption. Calcium is a multivalent cation that undergoes 'chelation' with tetracycline. They bind together to form an insoluble complex in the digestive tract that is too large to pass through the gut.
%20vaccination/og.png)
Patient information leaflet
Vaccination contre le virus respiratoire syncytial (VRS)
This led the US Food and Drug Administration (FDA) to approve Abrysvo, the RSV vaccine t... However, detailed analysis of the research data, and more recent studies of pregnant women who have had Abrysvo, show that there is no evidence to show that it is linked with preterm birth. The UK's Medicines and Healthcare products Regulatory Agency (MHRA).

Patient information leaflet
Insuline
Insulin is a hormone made naturally in the body by the pancreas. This hormone controls the level of sugar (glucose) in the blood. People who have type 1 di... Insulin is usually injected under the skin between 2-4 times a day. For more information on insulin, go to.

Patient information leaflet
Angioplastie coronarienne
Angioplastie coronarienne est a treatment to widen narrowed sections of the heart (coronary) arteries. It is also known as percutaneous coronary intervention (PCI). It involves the use of a thin, flexible tube (called a catheter) which is inserted into coronary arteries, via an artery in the wrist or groin and eventually the large blood vessels. It was.

Patient information leaflet
Médicaments contre l'épilepsie et effets secondaires
Editor's note Dr Krishna Vakharia , 13th September 2024 The Medicines and Healthcare products Regulatory agency has issued an alert to the use of valproate in men around the time of conception. Valproate use in men: as a precaution, men and their partners should use effective contraception; Medicines & Healthcare products Regulatory Agency, GOV.UK.
Lectures complémentaires et références
- KAT8 regulatory NSL complex subunit 1; MedlinePlus, National Library of Medicine.
- Itsara A, Vissers LE, Steinberg KM, Meyer KJ, Zody MC, Koolen DA, de Ligt J, Cuppen E, Baker C, Lee C, Graves TA, Wilson RK, Jenkins RB, Veltman JA, Eichler EE. Resolving the breakpoints of the 17q21.31 microdeletion syndrome with next-generation sequencing. Am J Hum Genet. 2012 Apr 6;90(4):599-613. doi: 10.1016/j.ajhg.2012.02.013.
- Koolen DA, Kramer JM, Neveling K, Nillesen WM, Moore-Barton HL, Elmslie FV, Toutain A, Amiel J, Malan V, Tsai AC, Cheung SW, Gilissen C, Verwiel ET, Martens S, Feuth T, Bongers EM, de Vries P, Scheffer H, Vissers LE, de Brouwer AP, Brunner HG, Veltman JA, Schenck A, Yntema HG, de Vries BB. Mutations in the chromatin modifier gene KANSL1 cause the 17q21.31 microdeletion syndrome. Nat Genet. 2012 Apr 29;44(6):639-41. doi: 10.1038/ng.2262.
- Zollino M, Orteschi D, Murdolo M, Lattante S, Battaglia D, Stefanini C, Mercuri E, Chiurazzi P, Neri G, Marangi G. Mutations in KANSL1 cause the 17q21.31 microdeletion syndrome phenotype. Nat Genet. 2012 Apr 29;44(6):636-8. doi: 10.1038/ng.2257.
Partagez vos pensées ou expériences avec les autres dans notre communautés de patients.
Inscrivez-vous à la newsletter Patient
Votre dose hebdomadaire de conseils de santé clairs et fiables - rédigés pour vous aider à vous sentir informé, confiant et maître de la situation.
En vous abonnant, vous acceptez notre Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.

